HCPCS C Codes – Outpatient PPS (Hospital Outpatient)

• C1052 – Hemostatic agent, gastrointestinal, topical
• C1062 – Intravertebral body fracture augmentation with implant (e.g., metal, polymer)
• C1600 – Catheter, transluminal intravascular lesion preparation device, bladed, sheathed (insertable)
• C1601 – Endoscope, single-use (i.e. disposable), pulmonary, imaging/illumination device (insertable)
• C1602 – Orthopedic/device/drug matrix/absorbable bone void filler, antimicrobial-eluting (implantable)
• C1603 – Retrieval device, insertable, laser (used to retrieve intravascular inferior vena cava filter)
• C1604 – Graft, transmural transvenous arterial bypass (implantable), with all delivery system components
• C1605 – Pacemaker, leadless, dual chamber (right atrial and right ventricular implantable components), rate-responsive, including all necessary components for implantation
• C1606 – Adapter, single-use (i.e. disposable), for attaching ultrasound system to upper gastrointestinal endoscope
• C1607 – Neurostimulator, integrated (implantable), rechargeable with all implantable and external components including charging system
• C1608 – Prosthesis, total, dual mobility, first carpometacarpal joint (implantable)
• C1609 – Vertebral device, motion-preserving, with screw fixation
• C1713 – Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)
• C1714 – Catheter, transluminal atherectomy, directional
• C1715 – Brachytherapy needle
• C1716 – Brachytherapy source, non-stranded, gold-198, per source
• C1717 – Brachytherapy source, non-stranded, high dose rate iridium-192, per source
• C1719 – Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source
• C1721 – Cardioverter-defibrillator, dual chamber (implantable)
• C1722 – Cardioverter-defibrillator, single chamber (implantable)
• C1724 – Catheter, transluminal atherectomy, rotational
• C1725 – Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)
• C1726 – Catheter, balloon dilatation, non-vascular
• C1727 – Catheter, balloon tissue dissector, non-vascular (insertable)
• C1728 – Catheter, brachytherapy seed administration
• C1729 – Catheter, drainage
• C1730 – Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes)
• C1731 – Catheter, electrophysiology, diagnostic, other than 3d mapping (20 or more electrodes)
• C1732 – Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping
• C1733 – Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, other than cool-tip
• C1734 – Orthopedic/device/drug matrix for opposing bone-to-bone or soft tissue-to bone (implantable)
• C1735 – Catheter(s), intravascular for renal denervation, radiofrequency, including all single use system components
• C1736 – Catheter(s), intravascular for renal denervation, ultrasound, including all single use system components
• C1737 – Joint fusion and fixation device(s), sacroiliac and pelvis, including all system components (implantable)
• C1738 – Powered, single-use (i.e. disposable) endoscopic ultrasound-guided biopsy device
• C1739 – Tissue marker, uniquely detectable and identifiable with probe/sensor, any method (implantable), with delivery system
• C1740 – Leadless electrode, transmitter, battery (all implantable), for sequential left ventricular pacing
• C1741 – Anchor/screw for bone fixation, absorbable, metallic (implantable)
• C1742 – Pressure monitoring system, compartmental intramuscular (implantable), continuous, including all components (e.g., introducer, sensor), excludes mobile (wireless) software application
• C1743 – Scaffold, endovascular non-coronary, resorbable drug eluting, with delivery system (implantable)
• C1747 – Endoscope, single-use (i.e. disposable), urinary tract, imaging/illumination device (insertable)
• C1748 – Endoscope, single-use (i.e. disposable), upper gi, imaging/illumination device (insertable)
• C1749 – Endoscope, retrograde imaging/illumination colonoscope device (implantable)
• C1750 – Catheter, hemodialysis/peritoneal, long-term
• C1751 – Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)
• C1752 – Catheter, hemodialysis/peritoneal, short-term
• C1753 – Catheter, intravascular ultrasound
• C1754 – Catheter, intradiscal
• C1755 – Catheter, intraspinal
• C1756 – Catheter, pacing, transesophageal
• C1757 – Catheter, thrombectomy/embolectomy
• C1758 – Catheter, ureteral
• C1759 – Catheter, intracardiac echocardiography
• C1760 – Closure device, vascular (implantable/insertable)
• C1761 – Catheter, transluminal intravascular lithotripsy, coronary
• C1762 – Connective tissue, human (includes fascia lata)
• C1763 – Connective tissue, non-human (includes synthetic)
• C1764 – Event recorder, cardiac (implantable)
• C1765 – Adhesion barrier
• C1766 – Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away
• C1767 – Generator, neurostimulator (implantable), non-rechargeable
• C1768 – Graft, vascular
• C1769 – Guide wire
• C1770 – Imaging coil, magnetic resonance (insertable)
• C1771 – Repair device, urinary, incontinence, with sling graft
• C1772 – Infusion pump, programmable (implantable)
• C1773 – Retrieval device, insertable (used to retrieve fractured medical devices)
• C1776 – Joint device (implantable)
• C1777 – Lead, cardioverter-defibrillator, endocardial single coil (implantable)
• C1778 – Lead, neurostimulator (implantable)
• C1779 – Lead, pacemaker, transvenous vdd single pass
• C1780 – Lens, intraocular (new technology)
• C1781 – Mesh (implantable)
• C1782 – Morcellator
• C1783 – Ocular implant, aqueous drainage assist device
• C1784 – Ocular device, intraoperative, detached retina
• C1785 – Pacemaker, dual chamber, rate-responsive (implantable)
• C1786 – Pacemaker, single chamber, rate-responsive (implantable)
• C1787 – Patient programmer, neurostimulator
• C1788 – Port, indwelling (implantable)
• C1789 – Prosthesis, breast (implantable)
• C1813 – Prosthesis, penile, inflatable
• C1814 – Retinal tamponade device, silicone oil
• C1815 – Prosthesis, urinary sphincter (implantable)
• C1816 – Receiver and/or transmitter, neurostimulator (implantable)
• C1817 – Septal defect implant system, intracardiac
• C1818 – Integrated keratoprosthesis
• C1819 – Surgical tissue localization and excision device (implantable)
• C1820 – Generator, neurostimulator (implantable), with rechargeable battery and charging system
• C1821 – Interspinous process distraction device (implantable)
• C1822 – Generator, neurostimulator (implantable), high frequency, with rechargeable battery and charging system
• C1823 – Generator, neurostimulator (implantable), non-rechargeable, with transvenous sensing and stimulation leads
• C1824 – Generator, cardiac contractility modulation (implantable)
• C1825 – Generator, neurostimulator (implantable), non-rechargeable with carotid sinus baroreceptor stimulation lead(s)
• C1826 – Generator, neurostimulator (implantable), includes closed feedback loop leads and all implantable components, with rechargeable battery and charging system
• C1827 – Generator, neurostimulator (implantable), non-rechargeable, with implantable stimulation lead and external paired stimulation controller
• C1830 – Powered bone marrow biopsy needle
• C1831 – Interbody cage, anterior, lateral or posterior, personalized (implantable)
• C1832 – Autograft suspension, including cell processing and application, and all system components
• C1833 – Monitor, cardiac, including intracardiac lead and all system components (implantable)
• C1839 – Iris prosthesis
• C1840 – Lens, intraocular (telescopic)
• C1874 – Stent, coated/covered, with delivery system
• C1875 – Stent, coated/covered, without delivery system
• C1876 – Stent, non-coated/non-covered, with delivery system
• C1877 – Stent, non-coated/non-covered, without delivery system
• C1878 – Material for vocal cord medialization, synthetic (implantable)
• C1880 – Vena cava filter
• C1881 – Dialysis access system (implantable)
• C1882 – Cardioverter-defibrillator, other than single or dual chamber (implantable)
• C1883 – Adapter/extension, pacing lead or neurostimulator lead (implantable)
• C1884 – Embolization protective system
• C1885 – Catheter, transluminal angioplasty, laser
• C1886 – Catheter, extravascular tissue ablation, any modality (insertable)
• C1887 – Catheter, guiding (may include infusion/perfusion capability)
• C1888 – Catheter, ablation, non-cardiac, endovascular (implantable)
• C1889 – Implantable/insertable device, not otherwise classified
• C1890 – No implantable/insertable device used with device-intensive procedures
• C1891 – Infusion pump, non-programmable, permanent (implantable)
• C1892 – Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away
• C1893 – Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away
• C1894 – Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser
• C1895 – Lead, cardioverter-defibrillator, endocardial dual coil (implantable)
• C1896 – Lead, cardioverter-defibrillator, other than endocardial single or dual coil (implantable)
• C1897 – Lead, neurostimulator test kit (implantable)
• C1898 – Lead, pacemaker, other than transvenous vdd single pass
• C1899 – Lead, pacemaker/cardioverter-defibrillator combination (implantable)
• C1900 – Lead, left ventricular coronary venous system
• C1982 – Catheter, pressure-generating, (e.g., one-way valve or occlusion balloon, intermittently or temporarily occluding)
• C2596 – Probe, image-guided, robotic, waterjet ablation
• C2613 – Lung biopsy plug with delivery system
• C2614 – Probe, percutaneous lumbar discectomy
• C2615 – Sealant, pulmonary, liquid
• C2616 – Brachytherapy source, non-stranded, yttrium-90, per source
• C2617 – Stent, non-coronary, temporary, without delivery system
• C2618 – Probe/needle, cryoablation
• C2619 – Pacemaker, dual chamber, non rate-responsive (implantable)
• C2620 – Pacemaker, single chamber, non rate-responsive (implantable)
• C2621 – Pacemaker, other than single or dual chamber (implantable)
• C2622 – Prosthesis, penile, non-inflatable
• C2623 – Catheter, transluminal angioplasty, drug-coated, non-laser
• C2624 – Implantable wireless pulmonary artery pressure sensor with delivery catheter, including all system components
• C2625 – Stent, non-coronary, temporary, with delivery system
• C2626 – Infusion pump, non-programmable, temporary (implantable)
• C2627 – Catheter, suprapubic/cystoscopic
• C2628 – Catheter, occlusion
• C2629 – Introducer/sheath, other than guiding, other than intracardiac electrophysiological, laser
• C2630 – Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, cool-tip
• C2631 – Repair device, urinary, incontinence, without sling graft
• C2634 – Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source
• C2635 – Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source
• C2636 – Brachytherapy linear source, non-stranded, palladium-103, per 1 mm
• C2637 – Brachytherapy source, non-stranded, ytterbium-169, per source
• C2638 – Brachytherapy source, stranded, iodine-125, per source
• C2639 – Brachytherapy source, non-stranded, iodine-125, per source
• C2640 – Brachytherapy source, stranded, palladium-103, per source
• C2641 – Brachytherapy source, non-stranded, palladium-103, per source
• C2642 – Brachytherapy source, stranded, cesium-131, per source
• C2643 – Brachytherapy source, non-stranded, cesium-131, per source
• C2644 – Brachytherapy source, cesium-131 chloride solution, per millicurie
• C2645 – Brachytherapy planar source, palladium-103, per square millimeter
• C2698 – Brachytherapy source, stranded, not otherwise specified, per source
• C2699 – Brachytherapy source, non-stranded, not otherwise specified, per source
• C7500 – Debridement, bone including epidermis, dermis, subcutaneous tissue, muscle and/or fascia, if performed, first 20 sq cm or less with manual preparation and insertion of deep (e.g., subfacial) drug-delivery device(s)
• C7501 – Percutaneous breast biopsies using stereotactic guidance, with placement of breast localization device(s) (e.g., clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral and bilateral (for single lesion biopsy, use appropriate code)
• C7502 – Percutaneous breast biopsies using magnetic resonance guidance, with placement of breast localization device(s) (e.g., clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral or bilateral (for single lesion biopsy, use appropriate code)
• C7503 – Open biopsy or excision of deep cervical node(s) with intraoperative identification (e.g., mapping) of sentinel lymph node(s) including injection of non-radioactive dye when performed
• C7504 – Percutaneous vertebroplasties (bone biopsies included when performed), first cervicothoracic and any additional cervicothoracic or lumbosacral vertebral bodies, unilateral or bilateral injection, inclusive of all imaging guidance
• C7505 – Percutaneous vertebroplasties (bone biopsies included when performed), first lumbosacral and any additional cervicothoracic or lumbosacral vertebral bodies, unilateral or bilateral injection, inclusive of all imaging guidance
• C7506 – Arthrodesis, interphalangeal joints, with or without internal fixation
• C7507 – Percutaneous vertebral augmentations, first thoracic and any additional thoracic or lumbar vertebral bodies, including cavity creations (fracture reductions and bone biopsies included when performed) using mechanical device (e.g., kyphoplasty), unilateral or bilateral cannulations, inclusive of all imaging guidance
• C7508 – Percutaneous vertebral augmentations, first lumbar and any additional thoracic or lumbar vertebral bodies, including cavity creations (fracture reductions and bone biopsies included when performed) using mechanical device (e.g., kyphoplasty), unilateral or bilateral cannulations, inclusive of all imaging guidance
• C7509 – Bronchoscopy, rigid or flexible, diagnostic with cell washing(s) when performed, with computer-assisted image-guided navigation, including fluoroscopic guidance when performed
• C7510 – Bronchoscopy, rigid or flexible, with bronchial alveolar lavage(s), with computer-assisted image-guided navigation, including fluoroscopic guidance when performed
• C7511 – Bronchoscopy, rigid or flexible, with single or multiple bronchial or endobronchial biopsy(ies), single or multiple sites, with computer-assisted image-guided navigation, including fluoroscopic guidance when performed
• C7512 – Bronchoscopy, rigid or flexible, with single or multiple bronchial or endobronchial biopsy(ies), single or multiple sites, with transendoscopic endobronchial ultrasound (ebus) during bronchoscopic diagnostic or therapeutic intervention(s) for peripheral lesion(s), including fluoroscopic guidance when performed
• C7513 – Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with transluminal balloon angioplasty of central dialysis segment, performed through dialysis circuit, including all required imaging, radiological supervision and interpretation, image documentation and report
• C7514 – Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with all angioplasty in the central dialysis segment, and transcatheter placement of intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all required imaging, radiological supervision and interpretation, image documentation and report
• C7515 – Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with dialysis circuit permanent endovascular embolization or occlusion of main circuit or any accessory veins, including all required imaging, radiological supervision and interpretation, image documentation and report
• C7516 – Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report
• C7517 – Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation
• C7518 – Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging, supervision, interpretation and report
• C7519 – Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress
• C7520 – Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) includes intraprocedural injection(s) for bypass graft angiography with iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation
• C7521 – Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography with right heart catheterization with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report
• C7522 – Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with right heart catheterization, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress
• C7523 – Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report
• C7524 – Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress
• C7525 – Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report
• C7526 – Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress
• C7527 – Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report
• C7528 – Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress
• C7529 – Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress
• C7530 – Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with transluminal balloon angioplasty, peripheral dialysis segment, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty and all angioplasty in the central dialysis segment, with transcatheter placement of intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all imaging, radiological supervision and interpretation, documentation and report
• C7531 – Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with transluminal angioplasty with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation
• C7532 – Transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), initial artery, open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery, with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation
• C7533 – Percutaneous transluminal coronary angioplasty, single major coronary artery or branch with transcatheter placement of radiation delivery device for subsequent coronary intravascular brachytherapy
• C7534 – Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with atherectomy, includes angioplasty within the same vessel, when performed with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation
• C7535 – Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with transluminal stent placement(s), includes angioplasty within the same vessel, when performed, with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation
• C7537 – Insertion of new or replacement of permanent pacemaker with atrial transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (e.g., for upgrade to dual chamber system)
• C7538 – Insertion of new or replacement of permanent pacemaker with ventricular transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (e.g., for upgrade to dual chamber system)
• C7539 – Insertion of new or replacement of permanent pacemaker with atrial and ventricular transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system)
• C7540 – Removal of permanent pacemaker pulse generator with replacement of pacemaker pulse generator, dual lead system, with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system)
• C7541 – Diagnostic endoscopic retrograde cholangiopancreatography (ercp), including collection of specimen(s) by brushing or washing, when performed, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)
• C7542 – Endoscopic retrograde cholangiopancreatography (ercp) with biopsy, single or multiple, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)
• C7543 – Endoscopic retrograde cholangiopancreatography (ercp) with sphincterotomy/papillotomy, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)
• C7544 – Endoscopic retrograde cholangiopancreatography (ercp) with removal of calculi/debris from biliary/pancreatic duct(s), with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)
• C7545 – Percutaneous exchange of biliary drainage catheter (eg, external, internal-external, or conversion of internal-external to external only), with removal of calculi/debris from biliary duct(s) and/or gallbladder, including destruction of calculi by any method (eg, mechanical, electrohydraulic, lithotripsy) when performed, including diagnostic cholangiography(ies) when performed, imaging guidance (eg, fluoroscopy), and all associated radiological supervision and interpretation
• C7546 – Removal and replacement of externally accessible nephroureteral catheter (eg, external/internal stent) requiring fluoroscopic guidance, with ureteral stricture balloon dilation, including imaging guidance and all associated radiological supervision and interpretation
• C7547 – Convert nephrostomy catheter to nephroureteral catheter, percutaneous via pre-existing nephrostomy tract, with ureteral stricture balloon dilation, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation
• C7548 – Exchange nephrostomy catheter, percutaneous, with ureteral stricture balloon dilation, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation
• C7549 – Change of ureterostomy tube or externally accessible ureteral stent via ileal conduit with ureteral stricture balloon dilation, including imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation
• C7550 – Cystourethroscopy, with biopsy(ies) with adjunctive blue light cystoscopy with fluorescent imaging agent
• C7551 – Excision of major peripheral nerve neuroma, except sciatic, with implantation of nerve end into bone or muscle
• C7552 – Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography and right heart catheterization with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress, initial vessel
• C7553 – Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed
• C7554 – Cystourethroscopy with adjunctive blue light cystoscopy with fluorescent imaging agent
• C7555 – Thyroidectomy, total or complete with parathyroid autotransplantation
• C7556 – Bronchoscopy, rigid or flexible, with bronchial alveolar lavage and transendoscopic endobronchial ultrasound (ebus) during bronchoscopic diagnostic or therapeutic intervention(s) for peripheral lesion(s), including fluoroscopic guidance, when performed
• C7557 – Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed and intraprocedural coronary fractional flow reserve (ffr) with 3d functional mapping of color-coded ffr values for the coronary tree, derived from coronary angiogram data, for real-time review and interpretation of possible atherosclerotic stenosis(es) intervention
• C7560 – Endoscopic retrograde cholangiopancreatography (ercp) with removal of foreign body(s) or stent(s) from biliary/pancreatic duct(s) and endoscopic cannulation of papilla with direct visualization of pancreatic/common bile duct(s)
• C7562 – Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed with intraprocedural coronary fractional flow reserve (ffr) with 3d functional mapping of color-coded ffr values for the coronary tree, derived from coronary angiogram data, for real-time review and interpretation of possible atherosclerotic stenosis(es) intervention
• C7563 – Transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery, initial artery and all additional arteries
• C7564 – Percutaneous transluminal mechanical thrombectomy, vein(s), including intraprocedural pharmacological thrombolytic injections and fluoroscopic guidance with intravascular ultrasound (noncoronary vessel(s)) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation
• C7565 – Repair of anterior abdominal hernia(s) (ie, epigastric, incisional, ventral, umbilical, spigelian), any approach (i.e., open, laparoscopic, robotic), recurrent, including implantation of mesh or other prosthesis when performed, total length of defect(s) less than 3 cm, reducible with removal of total or near total non-infected mesh or other prosthesis at the time of initial or recurrent anterior abdominal hernia repair or parastomal hernia repair
• C7566 – Arthrodesis, interphalangeal joints, with or without internal fixation, with autografts (includes obtaining grafts)
• C7567 – Bronchoscopy, rigid or flexible, including fluoroscopic guidance when performed, with transbronchial needle aspiration biopsy(s), trachea, main stem and/or lobar bronchus(i), with computer-assisted image-guided navigation
• C7568 – Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress
• C7569 – Percutaneous transluminal coronary angioplasty, single major coronary artery or branch with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report
• C7570 – Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with intraprocedural coronary fractional flow reserve (ffr) with 3d functional mapping of color-coded ffr values for the coronary tree, derived from coronary angiogram data, for real-time review and interpretation of possible atherosclerotic stenosis(es) intervention (list separately in addition to code for primary procedure)
• C7571 – Percutaneous transluminal coronary angioplasty, single major coronary artery or branch with percutaneous transluminal coronary lithotripsy
• C7900 – Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 15-29 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service
• C7901 – Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service
• C7902 – Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, each additional 15 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service (list separately in addition to code for primary service)
• C7903 – Group psychotherapy service for diagnosis, evaluation, or treatment of a mental health or substance use disorder provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service
• C8000 – Support device, extravascular, for arteriovenous fistula (implantable)
• C8001 – 3d anatomical segmentation imaging for preoperative planning, data preparation and transmission, obtained from previous diagnostic computed tomographic or magnetic resonance examination of the same anatomy
• C8002 – Preparation of skin cell suspension autograft, automated, including all enzymatic processing and device components (do not report with manual suspension preparation)
• C8003 – Implantation of medial knee extraarticular implantable shock absorber spanning the knee joint from distal femur to proximal tibia, open, includes measurements, positioning and adjustments, with imaging guidance (e.g., fluoroscopy)
• C8004 – Simulation angiogram with use of a pressure-generating catheter (e.g., one-way valve or occlusion balloon, intermittently or temporarily occluding), inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the angiogram, for subsequent therapeutic radioembolization of tumors
• C8005 – Bronchoscopy, rigid or flexible, non-thermal transbronchial ablation of lesion(s) by pulsed electric field (pef) energy, including fluoroscopic and/or ultrasound guidance, when performed, with computed tomography acquisition(s) and 3d rendering, computer-assisted, image-guided navigation, and endobronchial ultrasound (ebus) guided transtracheal and/or transbronchial sampling (e.g., aspiration[s]/biopsy[ies]) of lung(s) and all mediastinal and/or hilar lymph node stations or structures, and therapeutic intervention(s)
• C8006 – Insertion of pleural-peritoneal shunt with intercostal pump chamber, including imaging, injection(s) of contrast with radiological supervision and interpretation, when performed
• C8007 – Open implantation of hypoglossal nerve neurostimulator array and pulse generator, not requiring insertion of a separate distal respiratory sensor electrode or electrode array
• C8008 – Revision or replacement of hypoglossal nerve neurostimulator array including connection to existing pulse generator
• C8009 – Removal of hypoglossal nerve neurostimulator array and pulse generator
• C8011 – Open implantation of hypoglossal nerve(s) neurostimulator electrode array(s) and receiver, including external power source and all system components
• C8012 – Revision or replacement of hypoglossal nerve(s) neurostimulator electrode array(s) and receiver
• C8013 – Removal of hypoglossal nerve(s) neurostimulator electrode array(s) and receiver
• C8014 – Cystourethroscopy, with ureteroscopy and/or pyeloscopy, with lithotripsy, including use of a suction enabled ureteral access sheath, with irrigation (if performed)
• C8900 – Magnetic resonance angiography with contrast, abdomen
• C8901 – Magnetic resonance angiography without contrast, abdomen
• C8902 – Magnetic resonance angiography without contrast followed by with contrast, abdomen
• C8903 – Magnetic resonance imaging with contrast, breast; unilateral
• C8905 – Magnetic resonance imaging without contrast followed by with contrast, breast; unilateral
• C8906 – Magnetic resonance imaging with contrast, breast; bilateral
• C8908 – Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral
• C8909 – Magnetic resonance angiography with contrast, chest (excluding myocardium)
• C8910 – Magnetic resonance angiography without contrast, chest (excluding myocardium)
• C8911 – Magnetic resonance angiography without contrast followed by with contrast, chest (excluding myocardium)
• C8912 – Magnetic resonance angiography with contrast, lower extremity
• C8913 – Magnetic resonance angiography without contrast, lower extremity
• C8914 – Magnetic resonance angiography without contrast followed by with contrast, lower extremity
• C8918 – Magnetic resonance angiography with contrast, pelvis
• C8919 – Magnetic resonance angiography without contrast, pelvis
• C8920 – Magnetic resonance angiography without contrast followed by with contrast, pelvis
• C8921 – Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; complete
• C8922 – Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; follow-up or limited study
• C8923 – Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, without spectral or color doppler echocardiography
• C8924 – Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, follow-up or limited study
• C8925 – Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, real time with image documentation (2d) (with or without m-mode recording); including probe placement, image acquisition, interpretation and report
• C8926 – Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; including probe placement, image acquisition, interpretation and report
• C8927 – Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for monitoring purposes, including probe placement, real time 2-dimensional image acquisition and interpretation leading to ongoing (continuous) assessment of (dynamically changing) cardiac pumping function and to therapeutic measures on an immediate time basis
• C8928 – Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report
• C8929 – Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography
• C8930 – Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision
• C8931 – Magnetic resonance angiography with contrast, spinal canal and contents
• C8932 – Magnetic resonance angiography without contrast, spinal canal and contents
• C8933 – Magnetic resonance angiography without contrast followed by with contrast, spinal canal and contents
• C8934 – Magnetic resonance angiography with contrast, upper extremity
• C8935 – Magnetic resonance angiography without contrast, upper extremity
• C8936 – Magnetic resonance angiography without contrast followed by with contrast, upper extremity
• C8937 – Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure)
• C8957 – Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump
• C9047 – Injection, caplacizumab-yhdp, 1 mg
• C9067 – Gallium ga-68, dotatoc, diagnostic, 0.01 mci
• C9101 – Injection, oliceridine, 0.1 mg
• C9143 – Cocaine hydrochloride nasal solution (numbrino), 1 mg
• C9144 – Injection, bupivacaine (posimir), 1 mg
• C9176 – Tc-99m from domestically produced non-heu mo-99, [minimum 50 percent], full cost recovery add-on, per study dose
• C9250 – Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml
• C9254 – Injection, lacosamide, 1 mg
• C9257 – Injection, bevacizumab, 0.25 mg
• C9285 – Lidocaine 70 mg/tetracaine 70 mg, per patch
• C9293 – Injection, glucarpidase, 10 units
• C9311 – Injection, eplontersen, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
• C9312 – Injection, trabectedin (apotex), not therapeutically equivalent to j9362, 0.01 mg
• C9313 – Injection, pivekimab sunirine-pvzy, 0.01 mg
• C9352 – Microporous collagen implantable tube (neuragen nerve guide), per centimeter length
• C9353 – Microporous collagen implantable slit tube (neurawrap nerve protector), per centimeter length
• C9354 – Acellular pericardial tissue matrix of non-human origin (veritas), per square centimeter
• C9355 – Collagen nerve cuff (neuromatrix), per 0.5 centimeter length
• C9356 – Tendon, porous matrix of cross-linked collagen and glycosaminoglycan matrix (tenoglide tendon protector sheet), per square centimeter
• C9358 – Dermal substitute, native, non-denatured collagen, fetal bovine origin (surgimend collagen matrix), per 0.5 square centimeters
• C9359 – Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold putty, integra os osteoconductive scaffold putty), per 0.5 cc
• C9360 – Dermal substitute, native, non-denatured collagen, neonatal bovine origin (surgimend collagen matrix), per 0.5 square centimeters
• C9361 – Collagen matrix nerve wrap (neuromend collagen nerve wrap), per 0.5 centimeter length
• C9362 – Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold strip), per 0.5 cc
• C9363 – Skin substitute, integra meshed bilayer wound matrix, per square centimeter
• C9364 – Porcine implant, permacol, per square centimeter
• C9399 – Unclassified drugs or biologicals
• C9460 – Injection, cangrelor, 1 mg
• C9482 – Injection, sotalol hydrochloride, 1 mg
• C9488 – Injection, conivaptan hydrochloride, 1 mg
• C9507 – Plasma, high titer covid-19 convalescent, each unit
• C9600 – Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch
• C9601 – Percutaneous transcatheter placement of drug-eluting intracoronary stent(s), with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)
• C9602 – Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch
• C9603 – Percutaneous transluminal coronary atherectomy, with drug-eluting intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)
• C9604 – Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; single vessel
• C9605 – Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; each additional branch subtended by the bypass graft (list separately in addition to code for primary procedure)
• C9606 – Percutaneous transluminal revascularization of acute total/subtotal occlusion during acute myocardial infarction, coronary artery or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including aspiration thrombectomy when performed, single vessel
• C9607 – Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; single vessel
• C9608 – Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; each additional coronary artery, coronary artery branch, or bypass graft (list separately in addition to code for primary procedure)
• C9610 – Catheter, transluminal drug delivery with or without angioplasty, coronary, non-laser (insertable)
• C9725 – Placement of endorectal intracavitary applicator for high intensity brachytherapy
• C9726 – Placement and removal (if performed) of applicator into breast for intraoperative radiation therapy, add-on to primary breast procedure
• C9727 – Insertion of implants into the soft palate; minimum of three implants
• C9728 – Placement of interstitial device(s) for radiation therapy/surgery guidance (e.g., fiducial markers, dosimeter), for other than the following sites (any approach): abdomen, pelvis, prostate, retroperitoneum, thorax, single or multiple
• C9733 – Non-ophthalmic fluorescent vascular angiography
• C9734 – Focused ultrasound ablation/therapeutic intervention, other than uterine leiomyomata, with magnetic resonance (mr) guidance
• C9738 – Adjunctive blue light cystoscopy with fluorescent imaging agent (list separately in addition to code for primary procedure)
• C9739 – Cystourethroscopy, with insertion of transprostatic implant; 1 to 3 implants
• C9740 – Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants
• C9756 – Intraoperative near-infrared fluorescence lymphatic mapping of lymph node(s) (sentinel or tumor draining) with administration of indocyanine green (icg) (list separately in addition to code for primary procedure)
• C9757 – Laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy and excision of herniated intervertebral disc, and repair of annular defect with implantation of bone anchored annular closure device, including annular defect measurement, alignment and sizing assessment, and image guidance; 1 interspace, lumbar
• C9758 – Blinded procedure for nyha class iii/iv heart failure; transcatheter implantation of interatrial shunt or placebo control, including right heart catheterization, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study
• C9759 – Transcatheter intraoperative blood vessel microinfusion(s) (e.g., intraluminal, vascular wall and/or perivascular) therapy, any vessel, including radiological supervision and interpretation, when performed
• C9760 – Non-randomized, non-blinded procedure for nyha class ii, iii, iv heart failure; transcatheter implantation of interatrial shunt, including right and left heart catheterization, transeptal puncture, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study
• C9761 – Cystourethroscopy, with ureteroscopy and/or pyeloscopy, with lithotripsy, and ureteral catheterization for steerable vacuum aspiration of the kidney, collecting system, ureter, bladder, and urethra if necessary, with use of steerable ureteral catheter or suction-integrated ureteroscope
• C9762 – Cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with strain imaging
• C9763 – Cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with stress imaging
• C9764 – Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy, includes angioplasty within the same vessel(s), when performed
• C9765 – Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty within the same vessel(s), when performed
• C9766 – Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy and atherectomy, includes angioplasty within the same vessel(s), when performed
• C9767 – Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, includes angioplasty within the same vessel(s), when performed
• C9768 – Endoscopic ultrasound-guided direct measurement of hepatic portosystemic pressure gradient by any method (list separately in addition to code for primary procedure)
• C9772 – Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies), with intravascular lithotripsy, includes angioplasty within the same vessel (s), when performed
• C9773 – Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty within the same vessel(s), when performed
• C9774 – Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy and atherectomy, includes angioplasty within the same vessel (s), when performed
• C9775 – Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, includes angioplasty within the same vessel (s), when performed
• C9776 – Intraoperative near-infrared fluorescence imaging of major extra-hepatic bile duct(s) (e.g., cystic duct, common bile duct and common hepatic duct) with intravenous administration of indocyanine green (icg) (list separately in addition to code for primary procedure)
• C9777 – Esophageal mucosal integrity testing by electrical impedance, transoral, includes esophagoscopy or esophagogastroduodenoscopy
• C9778 – Colpopexy, vaginal; minimally invasive extra-peritoneal approach (sacrospinous)
• C9779 – Endoscopic submucosal dissection (esd), including endoscopy or colonoscopy, mucosal closure, when performed
• C9780 – Insertion of central venous catheter through central venous occlusion via inferior and superior approaches (e.g., inside-out technique), including imaging guidance
• C9781 – Arthroscopy, shoulder, surgical; with implantation of subacromial spacer (e.g., balloon), includes debridement (e.g., limited or extensive), subacromial decompression, acromioplasty, and biceps tenodesis when performed
• C9782 – Blinded procedure for new york heart association (nyha) class ii or iii heart failure, or canadian cardiovascular society (ccs) class iii or iv chronic refractory angina; transcatheter intramyocardial transplantation of autologous bone marrow cells (e.g., mononuclear) or placebo control, autologous bone marrow harvesting and preparation for transplantation, left heart catheterization including ventriculography, all laboratory services, and all imaging with or without guidance (e.g., transthoracic echocardiography, ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study
• C9783 – Blinded procedure for transcatheter implantation of coronary sinus reduction device or placebo control, including vascular access and closure, right heart catheterization, venous and coronary sinus angiography, imaging guidance and supervision and interpretation when performed in an approved investigational device exemption (ide) study
• C9785 – Endoscopic outlet reduction, gastric pouch application, with endoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components
• C9789 – Instillation of anti-neoplastic pharmacologic/biologic agent into renal pelvis, any method, including all imaging guidance, including volumetric measurement if performed
• C9791 – Magnetic resonance imaging with inhaled hyperpolarized xenon-129 contrast agent, chest, including preparation and administration of agent
• C9792 – Blinded or nonblinded procedure for symptomatic new york heart association (nyha) class ii, iii, iva heart failure; transcatheter implantation of left atrial to coronary sinus shunt using jugular vein access, including all imaging necessary to intra procedurally map the coronary sinus for optimal shunt placement (e.g., tee or ice ultrasound, fluoroscopy), performed under general anesthesia in an approved investigational device exemption (ide) study)
• C9793 – 3d predictive model generation for pre-planning of a cardiac procedure, using data from cardiac computed tomographic angiography and/or magnetic resonance imaging with report
• C9796 – Repair of enterocutaneous fistula small intestine or colon (excluding anorectal fistula) with plug (e.g., porcine small intestine submucosa [sis])
• C9797 – Vascular embolization or occlusion procedure with use of a pressure-generating catheter (e.g., one-way valve or occlusion balloon, intermittently or temporarily occluding), inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; for tumors, organ ischemia, or infarction
• C9804 – Elastomeric infusion pump (e.g., on-q* pump with bolus), including catheter and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
• C9806 – Rotary peristaltic infusion pump (e.g., ambit pump), including catheter and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
• C9807 – Nerve stimulator, percutaneous, peripheral (e.g., sprint peripheral nerve stimulation system), including electrode and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
• C9808 – Nerve cryoablation probe (e.g., cryoice, cryosphere, cryosphere max, cryoice cryosphere, cryoice cryo2), including probe and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
• C9809 – Cryoneurolysis needle (e.g., iovera system), including needle/tip and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
• C9810 – Water circulating motorized cold therapy device (e.g., iceman) including all system components (e.g. pads, console, disposable parts), non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
• C9811 – Electronic ambulatory infusion pump (e.g. sapphire pump), including all pump components, including disposable components , non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
• C9812 – Echogenic and/or nerve stimulator-guided nerve block needles (e.g. sonoplex, sonoblock, sonotap, stimuplex), non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
• C9813 – Perforated continuous infusion catheter set (e.g. infiltralong), including all components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
• C9814 – Continuous anesthesia echogenic conduction catheter set (e.g. sonolong, e-cath), including all components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
• C9815 – Linear peristaltic pain management infusion pump (e.g. cadd-solis ambulatory infusion pump), and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
• C9816 – Rotary peristaltic infusion pump (e.g., reusable ambit pump) including all disposable system components, reusable non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
• C9817 – Electronic cryo-pneumatic compression, pain management system (e.g. game ready grpro 2.1 system), including control unit, anatomically correct wrap(s), and other system component(s), non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
• C9818 – Suzetrigine, oral, 1 mg
• C9898 – Radiolabeled product provided during a hospital inpatient stay
• C9899 – Implanted prosthetic device, payable only for inpatients who do not have inpatient coverage
• C9901 – Endoscopic defect closure within the entire gastrointestinal tract, including upper endoscopy (including diagnostic, if performed) or colonoscopy (including diagnostic, if performed), with all system and tissue anchoring components

Discontinued C codes

• C1300 – Hyperbaric oxygen under pressure, full body chamber, per 30 minute intervalDiscontinued December 31, 2014
• C1834 – Pressure sensor system, includes all components (e.g., introducer, sensor), intramuscular (implantable), excludes mobile (wireless) software applicationDiscontinued March 31, 2023
• C1841 – Retinal prosthesis, includes all internal and external componentsDiscontinued December 31, 2022
• C1842 – Retinal prosthesis, includes all internal and external components; add-on to c1841Discontinued December 31, 2022
• C1849 – Skin substitute, synthetic, resorbable, per square centimeterDiscontinued December 31, 2022
• C5271 – Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface areaDiscontinued December 31, 2025
• C5272 – Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)Discontinued December 31, 2025
• C5273 – Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and childrenDiscontinued December 31, 2025
• C5274 – Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)Discontinued December 31, 2025
• C5275 – Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface areaDiscontinued December 31, 2025
• C5276 – Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)Discontinued December 31, 2025
• C5277 – Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and childrenDiscontinued December 31, 2025
• C5278 – Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)Discontinued December 31, 2025
• C7558 – Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performedDiscontinued December 31, 2024
• C8010 – Percutaneous placement of permanent common carotid embolic protection device, including all system components and imaging guidance; bilateralDiscontinued September 30, 2026
• C8904 – Magnetic resonance imaging without contrast, breast; unilateralDiscontinued December 31, 2018
• C8907 – Magnetic resonance imaging without contrast, breast; bilateralDiscontinued December 31, 2018
• C9014 – Injection, cerliponase alfa, 1 mgDiscontinued December 31, 2018
• C9015 – Injection, c-1 esterase inhibitor (human), haegarda, 10 unitsDiscontinued December 31, 2018
• C9016 – Injection, triptorelin extended release, 3.75 mgDiscontinued December 31, 2018
• C9021 – Injection, obinutuzumab, 10 mgDiscontinued December 31, 2014
• C9022 – Injection, elosulfase alfa, 1mgDiscontinued December 31, 2014
• C9023 – Injection, testosterone undecanoate, 1 mgDiscontinued December 31, 2014
• C9024 – Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabineDiscontinued December 31, 2018
• C9025 – Injection, ramucirumab, 5 mgDiscontinued December 31, 2015
• C9026 – Injection, vedolizumab, 1 mgDiscontinued December 31, 2015
• C9027 – Injection, pembrolizumab, 1 mgDiscontinued December 31, 2015
• C9028 – Injection, inotuzumab ozogamicin, 0.1 mgDiscontinued December 31, 2018
• C9029 – Injection, guselkumab, 1 mgDiscontinued December 31, 2018
• C9030 – Injection, copanlisib, 1 mgDiscontinued December 31, 2018
• C9031 – Lutetium lu 177, dotatate, therapeutic, 1 mciDiscontinued December 31, 2018
• C9032 – Injection, voretigene neparvovec-rzyl, 1 billion vector genomeDiscontinued December 31, 2018
• C9033 – Injection, fosnetupitant 235 mg and palonosetron 0.25 mgDiscontinued December 31, 2018
• C9034 – Injection, dexamethasone 9%, intraocular, 1 mcgDiscontinued December 31, 2018
• C9035 – Injection, aripiprazole lauroxil (aristada initio), 1 mgDiscontinued September 30, 2019
• C9036 – Injection, patisiran, 0.1 mgDiscontinued September 30, 2019
• C9037 – Injection, risperidone (perseris), 0.5 mgDiscontinued September 30, 2019
• C9038 – Injection, mogamulizumab-kpkc, 1 mgDiscontinued September 30, 2019
• C9039 – Injection, plazomicin, 5 mgDiscontinued September 30, 2019
• C9040 – Injection, fremanezumab-vfrm, 1mgDiscontinued September 30, 2019
• C9041 – Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mgDiscontinued June 30, 2020
• C9042 – Injection, bendamustine hcl (belrapzo), 1 mgDiscontinued June 30, 2019
• C9043 – Injection, levoleucovorin, 1 mgDiscontinued December 31, 2019
• C9044 – Injection, cemiplimab-rwlc, 1 mgDiscontinued September 30, 2019
• C9045 – Injection, moxetumomab pasudotox-tdfk, 0.01 mgDiscontinued September 30, 2019
• C9046 – Cocaine hydrochloride nasal solution (goprelto), 1 mgDiscontinued September 30, 2026
• C9048 – Dexamethasone, lacrimal ophthalmic insert, 0.1 mgDiscontinued September 30, 2019
• C9049 – Injection, tagraxofusp-erzs, 10 mcgDiscontinued September 30, 2019
• C9050 – Injection, emapalumab-lzsg, 1 mgDiscontinued September 30, 2019
• C9051 – Injection, omadacycline, 1 mgDiscontinued September 30, 2019
• C9052 – Injection, ravulizumab-cwvz, 10 mgDiscontinued September 30, 2019
• C9053 – Injection, crizanlizumab-tmca, 1 mgDiscontinued June 30, 2020
• C9054 – Injection, lefamulin (xenleta), 1 mgDiscontinued June 30, 2020
• C9055 – Injection, brexanolone, 1mgDiscontinued September 30, 2020
• C9056 – Injection, givosiran, 0.5 mgDiscontinued June 30, 2020
• C9057 – Injection, cetirizine hydrochloride, 1 mgDiscontinued June 30, 2020
• C9058 – Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo) 0.5 mgDiscontinued June 30, 2020
• C9059 – Injection, meloxicam, 1 mgDiscontinued September 30, 2020
• C9060 – Fluoroestradiol f18, diagnostic, 1 mciDiscontinued December 31, 2020
• C9061 – Injection, teprotumumab-trbw, 10 mgDiscontinued September 30, 2020
• C9062 – Injection, daratumumab 10 mg and hyaluronidase-fihjDiscontinued December 31, 2020
• C9063 – Injection, eptinezumab-jjmr, 1 mgDiscontinued September 30, 2020
• C9064 – Mitomycin pyelocalyceal instillation, 1 mgDiscontinued December 31, 2020
• C9065 – Injection, romidepsin, non-lyophilized (e.g. liquid), 1mgDiscontinued September 30, 2021
• C9066 – Injection, sacituzumab govitecan-hziy, 2.5 mgDiscontinued December 31, 2020
• C9068 – Copper cu-64, dotatate, diagnostic, 1 millicurieDiscontinued March 31, 2021
• C9069 – Injection, belantamab mafodontin-blmf, 0.5 mgDiscontinued March 31, 2021
• C9070 – Injection, tafasitamab-cxix, 2 mgDiscontinued March 31, 2021
• C9071 – Injection, viltolarsen, 10 mgDiscontinued March 31, 2021
• C9072 – Injection, immune globulin (asceniv), 500 mgDiscontinued March 31, 2021
• C9073 – Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic doseDiscontinued March 31, 2021
• C9074 – Injection, lumasiran, 0.5 mgDiscontinued June 30, 2021
• C9075 – Injection, casimersen, 10 mgDiscontinued September 30, 2021
• C9076 – Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic doseDiscontinued September 30, 2021
• C9077 – Injection, cabotegravir and rilpivirine, 2mg/3mgDiscontinued September 30, 2021
• C9078 – Injection, trilaciclib, 1 mgDiscontinued September 30, 2021
• C9079 – Injection, evinacumab-dgnb, 5 mgDiscontinued September 30, 2021
• C9080 – Injection, melphalan flufenamide hydrochloride, 1 mgDiscontinued September 30, 2021
• C9081 – Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic doseDiscontinued December 31, 2021
• C9082 – Injection, dostarlimab-gxly, 100 mgDiscontinued December 31, 2021
• C9083 – Injection, amivantamab-vmjw, 10 mgDiscontinued December 31, 2021
• C9084 – Injection, loncastuximab tesirine-lpyl, 0.1 mgDiscontinued March 31, 2022
• C9085 – Injection, avalglucosidase alfa-ngpt, 4 mgDiscontinued March 31, 2022
• C9086 – Injection, anifrolumab-fnia, 1 mgDiscontinued March 31, 2022
• C9087 – Injection, cyclophosphamide, (auromedics), 10 mgDiscontinued March 31, 2022
• C9088 – Instillation, bupivacaine and meloxicam, 1 mg/0.03 mgDiscontinued September 30, 2025
• C9089 – Bupivacaine, collagen-matrix implant, 1 mgDiscontinued December 31, 2025
• C9090 – Injection, plasminogen, human-tvmh, 1 mgDiscontinued June 30, 2022
• C9091 – Injection, sirolimus protein-bound particles, 1 mgDiscontinued June 30, 2022
• C9092 – Injection, triamcinolone acetonide, suprachoroidal (xipere), 1 mgDiscontinued June 30, 2022
• C9093 – Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mgDiscontinued June 30, 2022
• C9094 – Inj, sutimlimab-jome, 10 mgDiscontinued September 30, 2022
• C9095 – Inj, tebentafusp-tebn, 1 mcgDiscontinued September 30, 2022
• C9096 – Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgramDiscontinued September 30, 2022
• C9097 – Inj, faricimab-svoa, 0.1 mgDiscontinued September 30, 2022
• C9098 – Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic doseDiscontinued September 30, 2022
• C9113 – Injection, pantoprazole sodium, per vialDiscontinued June 30, 2024
• C9121 – Injection, argatroban, per 5 mgDiscontinued December 31, 2016
• C9122 – Mometasone furoate sinus implant, 10 micrograms (sinuva)Discontinued March 31, 2021
• C9132 – Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activityDiscontinued June 30, 2021
• C9133 – Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.Discontinued December 31, 2014
• C9134 – Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.Discontinued December 31, 2014
• C9135 – Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.Discontinued December 31, 2014
• C9136 – Injection, factor viii, fc fusion protein, (recombinant), per i.u.Discontinued March 31, 2015
• C9137 – Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.Discontinued December 31, 2016
• C9138 – Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.Discontinued December 31, 2016
• C9139 – Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.Discontinued December 31, 2016
• C9140 – Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.Discontinued December 31, 2017
• C9141 – Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.Discontinued June 30, 2019
• C9142 – Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mgDiscontinued December 31, 2022
• C9145 – Injection, aprepitant, (aponvie), 1 mgDiscontinued March 31, 2026
• C9146 – Injection, mirvetuximab soravtansine-gynx, 1 mgDiscontinued June 30, 2023
• C9147 – Injection, tremelimumab-actl, 1 mgDiscontinued June 30, 2023
• C9148 – Injection, teclistamab-cqyv, 0.5 mgDiscontinued June 30, 2023
• C9149 – Injection, teplizumab-mzwv, 5 mcgDiscontinued June 30, 2023
• C9150 – Xenon xe-129 hyperpolarized gas, diagnostic, per study doseDiscontinued September 30, 2024
• C9151 – Injection, pegcetacoplan, 1 mgDiscontinued September 30, 2023
• C9152 – Injection, aripiprazole, (abilify asimtufii), 1 mgDiscontinued December 31, 2023
• C9153 – Injection, amisulpride, 1 mgDiscontinued December 31, 2023
• C9154 – Injection, buprenorphine extended-release (brixadi), 1 mgDiscontinued December 31, 2023
• C9155 – Injection, epcoritamab-bysp, 0.16 mgDiscontinued December 31, 2023
• C9156 – Flotufolastat f 18, diagnostic, 1 millicurieDiscontinued December 31, 2023
• C9157 – Injection, tofersen, 1 mgDiscontinued December 31, 2023
• C9158 – Injection, risperidone, (uzedy), 1 mgDiscontinued December 31, 2023
• C9159 – Injection, prothrombin complex concentrate (human), balfaxar, per i.u. of factor ix activityDiscontinued March 31, 2024
• C9160 – Injection, daxibotulinumtoxina-lanm, 1 unitDiscontinued March 31, 2024
• C9161 – Injection, aflibercept hd, 1 mgDiscontinued March 31, 2024
• C9162 – Injection, avacincaptad pegol, 0.1 mgDiscontinued March 31, 2024
• C9163 – Injection, talquetamab-tgvs, 0.25 mgDiscontinued March 31, 2024
• C9164 – Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)Discontinued March 31, 2024
• C9165 – Injection, elranatamab-bcmm, 1 mgDiscontinued March 31, 2024
• C9166 – Injection, secukinumab, intravenous, 1 mgDiscontinued June 30, 2024
• C9167 – Injection, adamts13, recombinant-krhn, 10 iuDiscontinued June 30, 2024
• C9168 – Injection, mirikizumab-mrkz, 1 mgDiscontinued June 30, 2024
• C9169 – Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgramDiscontinued December 31, 2024
• C9170 – Injection, tarlatamab-dlle, 1 mgDiscontinued December 31, 2024
• C9171 – Injection, pegulicianine, 1 mgDiscontinued December 31, 2024
• C9172 – Injection, fidanacogene elaparvovec-dzkt, per therapeutic doseDiscontinued December 31, 2024
• C9173 – Injection, filgrastim-txid (nypozi), biosimilar, 1 microgramDiscontinued June 30, 2025
• C9174 – Injection, datopotamab deruxtecan-dlnk, 1 mgDiscontinued September 30, 2025
• C9175 – Injection, treosulfan, 50 mgDiscontinued September 30, 2025
• C9248 – Injection, clevidipine butyrate, 1 mgDiscontinued September 30, 2025
• C9275 – Injection, hexaminolevulinate hydrochloride, 100 mg, per study doseDiscontinued December 31, 2018
• C9290 – Injection, bupivacaine liposome, 1 mgDiscontinued December 31, 2024
• C9300 – Injection, indigotindisulfonate sodium, 1 mgDiscontinued June 30, 2025
• C9301 – Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic doseDiscontinued June 30, 2025
• C9302 – Injection, zanidatamab-hrii, 2 mgDiscontinued June 30, 2025
• C9303 – Injection, zolbetuximab-clzb, 1 mgDiscontinued June 30, 2025
• C9304 – Injection, marstacimab-hncq, 0.5 mgDiscontinued June 30, 2025
• C9305 – Injection, nipocalimab-aahu, 3 mgDiscontinued December 31, 2025
• C9306 – Injection, telisotuzumab vedotin-tllv, 1 mgDiscontinued December 31, 2025
• C9307 – Injection, linvoseltamab-gcpt, 1 mgDiscontinued March 31, 2026
• C9308 – Injection, carboplatin (avyxa), 1 mgDiscontinued March 31, 2026
• C9309 – Injection, onasemnogene abeparvovec-brve, per treatmentDiscontinued June 30, 2026
• C9310 – Injection, leucovorin calcium (avyxa), 1 mgDiscontinued September 30, 2026
• C9349 – Puraply, and puraply antimicrobial, any type, per square centimeterDiscontinued December 31, 2016
• C9407 – Iodine i-131 iobenguane, diagnostic, 1 millicurieDiscontinued December 31, 2019
• C9408 – Iodine i-131 iobenguane, therapeutic, 1 millicurieDiscontinued December 31, 2019
• C9441 – Injection, ferric carboxymaltose, 1 mgDiscontinued June 30, 2014
• C9442 – Injection, belinostat, 10 mgDiscontinued December 31, 2015
• C9443 – Injection, dalbavancin, 10 mgDiscontinued December 31, 2015
• C9444 – Injection, oritavancin, 10 mgDiscontinued December 31, 2015
• C9445 – Injection, c-1 esterase inhibitor (recombinant), ruconest, 10 unitsDiscontinued December 31, 2015
• C9446 – Injection, tedizolid phosphate, 1 mgDiscontinued December 31, 2015
• C9447 – Injection, phenylephrine and ketorolac, 4 ml vialDiscontinued September 30, 2019
• C9448 – Netupitant 300 mg and palonosetron 0.5 mg, oralDiscontinued June 30, 2015
• C9449 – Injection, blinatumomab, 1 mcgDiscontinued December 31, 2015
• C9450 – Injection, fluocinolone acetonide intravitreal implant, 0.01 mgDiscontinued December 31, 2015
• C9451 – Injection, peramivir, 1 mgDiscontinued December 31, 2015
• C9452 – Injection, ceftolozane 50 mg and tazobactam 25 mgDiscontinued December 31, 2015
• C9453 – Injection, nivolumab, 1 mgDiscontinued December 31, 2015
• C9454 – Injection, pasireotide long acting, 1 mgDiscontinued December 31, 2015
• C9455 – Injection, siltuximab, 10 mgDiscontinued December 31, 2015
• C9456 – Injection, isavuconazonium sulfate, 1 mgDiscontinued December 31, 2015
• C9457 – Injection, sulfur hexafluoride lipid microsphere, per mlDiscontinued December 31, 2015
• C9458 – Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuriesDiscontinued June 30, 2016
• C9459 – Flutemetamol f18, diagnostic, per study dose, up to 5 millicuriesDiscontinued June 30, 2016
• C9461 – Choline c 11, diagnostic, per study doseDiscontinued December 31, 2016
• C9462 – Injection, delafloxacin, 1 mgDiscontinued September 30, 2026
• C9463 – Injection, aprepitant, 1 mgDiscontinued December 31, 2018
• C9464 – Injection, rolapitant, 0.5 mgDiscontinued December 31, 2018
• C9465 – Hyaluronan or derivative, durolane, for intra-articular injection, per doseDiscontinued December 31, 2018
• C9466 – Injection, benralizumab, 1 mgDiscontinued December 31, 2018
• C9467 – Injection, rituximab and hyaluronidase, 10 mgDiscontinued December 31, 2018
• C9468 – Injection, factor ix (antihemophilic factor, recombinant), glycopegylated, rebinyn, 1 i.u.Discontinued December 31, 2018
• C9469 – Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mgDiscontinued June 30, 2018
• C9470 – Injection, aripiprazole lauroxil, 1 mgDiscontinued December 31, 2016
• C9471 – Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mgDiscontinued December 31, 2016
• C9472 – Injection, talimogene laherparepvec, 1 million plaque forming units (pfu)Discontinued December 31, 2016
• C9473 – Injection, mepolizumab, 1 mgDiscontinued December 31, 2016
• C9474 – Injection, irinotecan liposome, 1 mgDiscontinued December 31, 2016
• C9475 – Injection, necitumumab, 1 mgDiscontinued December 31, 2016
• C9476 – Injection, daratumumab, 10 mgDiscontinued December 31, 2016
• C9477 – Injection, elotuzumab, 1 mgDiscontinued December 31, 2016
• C9478 – Injection, sebelipase alfa, 1 mgDiscontinued December 31, 2016
• C9479 – Instillation, ciprofloxacin otic suspension, 6 mgDiscontinued December 31, 2016
• C9480 – Injection, trabectedin, 0.1 mgDiscontinued December 31, 2016
• C9481 – Injection, reslizumab, 1 mgDiscontinued December 31, 2016
• C9483 – Injection, atezolizumab, 10 mgDiscontinued December 31, 2017
• C9484 – Injection, eteplirsen, 10 mgDiscontinued December 31, 2017
• C9485 – Injection, olaratumab, 10 mgDiscontinued December 31, 2017
• C9486 – Injection, granisetron extended release, 0.1 mgDiscontinued December 31, 2017
• C9487 – Ustekinumab, for intravenous injection, 1 mgDiscontinued June 30, 2017
• C9489 – Injection, nusinersen, 0.1 mgDiscontinued December 31, 2017
• C9490 – Injection, bezlotoxumab, 10 mgDiscontinued December 31, 2017
• C9491 – Injection, avelumab, 10 mgDiscontinued December 31, 2017
• C9492 – Injection, durvalumab, 10 mgDiscontinued December 31, 2018
• C9493 – Injection, edaravone, 1 mgDiscontinued December 31, 2018
• C9494 – Injection, ocrelizumab, 1 mgDiscontinued December 31, 2017
• C9497 – Loxapine, inhalation powder, 10 mgDiscontinued December 31, 2018
• C9724 – Endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopyDiscontinued December 31, 2015
• C9735 – Anoscopy; with directed submucosal injection(s), any substanceDiscontinued December 31, 2014
• C9737 – Laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band)Discontinued June 30, 2015
• C9741 – Right heart catheterization with implantation of wireless pressure sensor in the pulmonary artery, including any type of measurement, angiography, imaging supervision, interpretation, and reportDiscontinued December 31, 2018
• C9742 – Laryngoscopy, flexible fiberoptic, with injection into vocal cord(s), therapeutic, including diagnostic laryngoscopy, if performedDiscontinued December 31, 2016
• C9743 – Injection/implantation of bulking or spacer material (any type) with or without image guidance (not to be used if a more specific code applies)Discontinued June 30, 2016
• C9744 – Ultrasound, abdominal, with contrastDiscontinued December 31, 2018
• C9745 – Nasal endoscopy, surgical; balloon dilation of eustachian tubeDiscontinued December 31, 2020
• C9746 – Transperineal implantation of permanent adjustable balloon continence device, with cystourethroscopy, when performed and/or fluoroscopy, when performedDiscontinued June 30, 2019
• C9747 – Ablation of prostate, transrectal, high intensity focused ultrasound (hifu), including imaging guidanceDiscontinued December 31, 2020
• C9748 – Transurethral destruction of prostate tissue; by radiofrequency water vapor (steam) thermal therapyDiscontinued December 31, 2018
• C9749 – Repair of nasal vestibular lateral wall stenosis with implant(s)Discontinued December 31, 2020
• C9750 – Insertion or removal and replacement of intracardiac ischemia monitoring system including imaging supervision and interpretation and peri-operative interrogation and programming; complete system (includes device and electrode)Discontinued December 31, 2018
• C9751 – Bronchoscopy, rigid or flexible, transbronchial ablation of lesion(s) by microwave energy, including fluoroscopic guidance, when performed, with computed tomography acquisition(s) and 3-d rendering, computer-assisted, image-guided navigation, and endobronchial ultrasound (ebus) guided transtracheal and/or transbronchial sampling (e.g., aspiration[s]/biopsy[ies]) and all mediastinal and/or hilar lymph node stations or structures and therapeutic intervention(s)Discontinued December 31, 2025
• C9752 – Destruction of intraosseous basivertebral nerve, first two vertebral bodies, including imaging guidance (e.g., fluoroscopy), lumbar/sacrumDiscontinued December 31, 2021
• C9753 – Destruction of intraosseous basivertebral nerve, each additional vertebral body, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum (list separately in addition to code for primary procedure)Discontinued December 31, 2021
• C9754 – Creation of arteriovenous fistula, percutaneous; direct, any site, including all imaging and radiologic supervision and interpretation, when performed and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization, when performed)Discontinued June 30, 2020
• C9755 – Creation of arteriovenous fistula, percutaneous using magnetic-guided arterial and venous catheters and radiofrequency energy, including flow-directing procedures (e.g., vascular coil embolization with radiologic supervision and interpretation, when performed) and fistulogram(s), angiography, venography, and/or ultrasound, with radiologic supervision and interpretation, when performedDiscontinued June 30, 2020
• C9769 – Cystourethroscopy, with insertion of temporary prostatic implant/stent with fixation/anchor and incisional strutsDiscontinued December 31, 2024
• C9770 – Vitrectomy, mechanical, pars plana approach, with subretinal injection of pharmacologic/biologic agentDiscontinued December 31, 2023
• C9771 – Nasal/sinus endoscopy, cryoablation nasal tissue(s) and/or nerve(s), unilateral or bilateralDiscontinued December 31, 2023
• C9784 – Gastric restrictive procedure, endoscopic sleeve gastroplasty, with esophagogastroduodenoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring componentsDiscontinued December 31, 2025
• C9786 – Echocardiography image post processing for computer aided detection of heart failure with preserved ejection fraction, including interpretation and reportDiscontinued December 31, 2024
• C9787 – Gastric electrophysiology mapping with simultaneous patient symptom profilingDiscontinued June 30, 2024
• C9788 – Opto-acoustic imaging, breast (including axilla when performed), unilateral, with image documentation, analysis and report, obtained with ultrasound examinationDiscontinued December 31, 2023
• C9790 – Histotripsy (i.e., non-thermal ablation via acoustic energy delivery) of malignant renal tissue, including image guidanceDiscontinued June 30, 2024
• C9794 – Therapeutic radiology simulation-aided field setting; complex, including acquisition of pet and ct imaging data required for radiopharmaceutical-directed radiation therapy treatment planning (i.e., modeling)Discontinued December 31, 2024
• C9795 – Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance and real-time positron emissions-based delivery adjustments to 1 or more lesions, entire course not to exceed 5 fractionsDiscontinued December 31, 2024
• C9800 – Dermal injection procedure(s) for facial lipodystrophy syndrome (lds) and provision of radiesse or sculptra dermal filler, including all items and suppliesDiscontinued December 31, 2016
• C9803 – Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen sourceDiscontinued December 31, 2023